IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q4 2017 Holdings

Filed 2018-02-13 | 11 holdings | $286.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$117.2K3,100,14641.0%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$99.9K1,672,71434.9%
Epizyme, Inc.(EPZMEUR)COM29428V104$19.6K1,558,1086.8%
Insmed Incorporated(INSM)COM457669307$16.2K518,6455.6%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$12.0K1,043,8324.2%
Acceleron Pharma Inc.(XLRN)COM00434H108$10.4K244,7563.6%
Denali Therapeutics Inc.(DNLI)COM24823R105$3.9K250,0001.4%
Juno Therapeutics, Inc.COM48205A109$3.9K85,0001.4%
uniQure N.V.(QURE)SHSN90064101$2.1K109,3500.7%
Loxo Oncology, Inc.COM548862101$1.0K11,9000.4%
Alder BioPharmaceuticals, Inc.CallCOM014339905$4024,0000.0%